CRISPR Therapeutics
CRSP
#3179
Rank
$3.85 B
Marketcap
$45.27
Share price
-0.22%
Change (1 day)
5.13%
Change (1 year)

CRISPR Therapeutics (CRSP) - Net assets

Net assets on the balance sheet as of June 2024 : $1.98 B

According to CRISPR Therapeutics's latest financial reports the company has $1.98 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

CRISPR Therapeutics - Net assets on balance sheet (from 2015 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$1.88 B0.39%
2022-12-31$$1.87 B-21.84%
2021-12-31$$2.39 B44.18%
2020-12-31$$1.66 B77.15%
2019-12-31$$0.93 B139.53%
2018-12-31$$0.39 B108.8%
2017-12-31$$0.18 B-19.33%
2016-12-31$$0.23 B-899.5%
2015-12-31$-$29.13 M317.61%
2014-12-31$-$6.98 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$0.30 B-84.73%๐Ÿ‡บ๐Ÿ‡ธ USA